Board of RHI Magnesita India approves allotment of 2.7 cr equity shares for acquisition of Dalmia OCL

Image
Capital Market
Last Updated : Jan 06 2023 | 10:04 AM IST

At meeting held on 05 January 2023

The Board of RHI Magnesita India at its meeting held on 05 January 2023 has approved the allotment of 2.70 crore equity shares at issue price of Rs 632.5029 per share to Dalmia Bharat Refractories (DBRL) for consideration other than cash in exchange of 8,24,83,642 equity shares of Dalmia OCL (DOCL), representing 100% equity share capital of DOCL from DBRL, by virtue of which DOCL shall become a wholly owned subsidiary of the company.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Subscribe to Business Standard digital and get complimentary access to The New York Times

Quarterly Starter

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

Save 46%

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Access to Exclusive Premium Stories Online

  • Over 30 behind the paywall stories daily, handpicked by our editors for subscribers

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 06 2023 | 9:31 AM IST

Next Story